Showing results (201-210 of 425) with videos related to
Sort By:
Pageof 43
British Medical Journal|December 12, 1970
Outcome of recent thromboembolic occlusions of limb arteries treated with streptokinaseA Amery, W Deloof, J Vermylen, et al.Acta Neurologica Scandinavica|August 1, 1991
Diagnostic significance of antinuclear antibodies in neurologic patientsB Michielsens, M Walravens, J Vermylen, et al.American Journal of Obstetrics and Gynecology|May 1, 1995
Intrauterine endoscopic creation of urinary tract obstruction in the fetal lamb: a model for fetal surgeryJ A Deprest, F I Luks, K H Peers, et al.Health Physics|February 1, 1996
Statistical analysis of real-time, environmental radon monitoring results at the Fernald Environmental Management ProjectN Liu, H B Spitz, L TomczakCellular Immunology|February 1, 1985
Effects of thromboxane A2 on lymphocyte proliferationJ L Ceuppens, S Vertessen, H Deckmyn, et al.Haemostasis|January 1, 1987
Continuous inhibition of serotonin-induced platelet aggregation during chronic ketanserin administration to man can be detected after plasma pH controlJ Arnout, M van Russelt, H Deckmyn, et al.Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Air pollution and thrombosis: an experimental approachA Nemmar, B Nemery, M F Hoylaerts, et al.Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 1995
[Inhibition of integrin function prevents restenosis following vascular injury]H Matsuno, M F Hoylaerts, J Vermylen, et al.Circulation|November 1, 1994
Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formationH Matsuno, J M Stassen, J Vermylen, et al.Platelets|November 4, 2010
Epinephrine induces a late thromboxane-dependent platelet shape change and enhances synergistically the shape change induced by other platelet agonistsD Blockmans, H Deckmyn, R De Vos, et al.Pageof 43